CHMG

Analyst Note: Chemung Financial Corporation (CHMG)

Date: 2026-06-13 Current Price: $70.97

1. Structural Readiness

• Conservative Entry: Not yet actionable. A conservative entry requires a confirmed breakout above the coil resistance.
• Aggressive/Pre-Breakout Entry: Not recommended as a standalone signal; the setup is currently in the accumulation/pullback phase.
• Breakout Level: Not yet established.
• Current Price: $70.97.
• Extension: Not applicable (price is within the coil structure, not extended above it).
• ATR Context: Current ATR is 3.1% (Productive). This sits within the historical "sweet spot" (4–6% is ideal, but 3.1% indicates manageable volatility for a micro-cap financial, distinct from the "weak" <2.5% or "extreme" >8% buckets).

2. Thesis Layer

• Thesis Classification: Tactical / Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this name as of 2026-06-13.
• Judgment Framework: The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the underlying business fundamentals (loan growth, NII expansion, regional economic tailwinds). Do not invent a macro narrative; the setup is the primary driver here.

3. Business Overview

Chemung Financial Corporation (CFC) operates as a regional bank holding company with a primary focus on New York and Pennsylvania.

• Core Operations: Through its subsidiary, Chemung Canal Trust Company, and CFS, the Corporation provides a comprehensive suite of financial services. This includes demand, savings, and time deposits; commercial, residential, and consumer loans; and a robust wealth management division (WMG).
• Revenue Drivers:
• Net Interest Income (NII): The primary income source. In Q1 2026, NII increased 19.0% ($3.8 million) to $23.6 million year-over-year. This growth was driven by a $3.4 million increase in interest income on loans and a $2.6 million decrease in interest expense on deposits.
• Fee Income: Wealth Management (WMG) is the largest component of non-interest income, managing $2.338 billion in assets as of December 31, 2025.
• Loan Portfolio Dynamics:
• Commercial Growth: Average balances of total commercial loans increased by $233.0 million year-over-year. This growth is attributed to the Capital Bank division (Albany market) and the Canal Bank division (Western New York).
• Residential Mortgage: Average balances increased by $10.7 million, driven by higher origination activity and a strategic decision to retain a higher proportion of originated loans for investment.
• Yield Improvement: The average yield on residential mortgage loans increased, attributed to the origination of higher-yielding loans in 2025 and early 2026.
• Regional Context: The company serves 13 counties in New York and Bradford County in Pennsylvania, operating through 31 branch locations with 348 full-time equivalent employees.
• Capital Structure: The Corporation issued $45.0 million of ten-year subordinated notes in 2025 to fund growth.

4. Archetype and Conviction

• Archetype: Growth Leader.
• *Fit:* The company demonstrates clear top-line growth in its core lending segments (Commercial +$233M, Residential +$10.7M) and expanding Net Interest Income (+19%). The retention of loans for investment suggests a strategy to capture yield in a potentially higher-rate environment (or at least a stable one).
• Valuation Context:
• Forward consensus EPS is $7.15 for FY1 and $7.53 for FY2.
• At a current price of $70.97, the stock trades at approximately 9.9x FY1 EPS and 9.4x FY2 EPS. This valuation implies a market expectation of sustained earnings growth, consistent with the "Growth Leader" archetype.
• Conviction Stack:
• Thesis Strength: Low (Tactical only, no macro thesis).
• Evidence Quality: High. The evidence (E1–E22) provides granular, point-in-time data on loan growth, NII expansion, and regional economic catalysts (semiconductor and biotech investments in the Capital Region).
• Rerating Potential: Moderate. The combination of double-digit NII growth and a valuation under 10x forward earnings suggests potential for multiple expansion if the regional economic tailwinds (semiconductor/biotech) materialize as management expects.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen the Case:
• A confirmed daily close above the coil resistance level (breakout).
• Continued sequential growth in commercial loan balances beyond the $233M YoY increase.
• Confirmation that the $10 billion semiconductor facility and Regeneron's $2 billion investment (announced in Q1 2026) are driving local deposit growth or loan demand in the Capital Region.
• What Would Invalidate the Case:
• A significant deterioration in Net Interest Income or a reversal in loan growth trends.
• Failure of the regional economic catalysts (e.g., delays in the EUV facility or Regeneron project) leading to a contraction in local economic activity.
• Gaps in Evidence:
• Asset Quality: No specific data on Non-Performing Assets (NPA) or Net Charge-Offs (NCO) for Q1 2026 is provided in the evidence block.
• Management Guidance: While management expectations regarding regional growth are noted, specific forward guidance for 2026 full-year EPS or NII is not explicitly quoted in the evidence (only consensus estimates are available).

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Q1 2026 Net Interest Income up 19% to $23.6M; Commercial loan balances up $233M YoY; Forward EPS of $7.15 implies <10x valuation; Regional economic catalysts (semiconductor/biotech) in Capital Region. Key risks: Setup is "Forming" not "Confirmed" (no breakout yet); No named secular thesis; Lack of asset quality data (NPA/NCO) in current evidence; Regional concentration risk in NY/PA. Sizing hint: Position size should reflect the "Forming" status; treat as a partial position pending a confirmed breakout above the coil resistance. Expected path: Management expects continued loan growth driven by regional industrial expansion; if the regional economy performs as anticipated, the stock should consolidate and eventually break out to re-rate. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).